On April 17, the World Federation of Hemophilia (WFH) is inviting our community to come together and work towards reaching the shared vision of Treatment...
Access to safe and effective treatment products continues to improve each year due to the tireless advocacy from the global bleeding disorders community. This strategic priority...
Inhibitors—antibodies to infused factor VIII or factor IX produced by the immune system, making treatment ineffective—are the foremost treatment complication faced by people with hemophilia...
Preparations are underway for the World Federation of Hemophilia (WFH) 2016 Global NMO Training, which will take place from July 20-23, 2016 in Orlando, USA....
This year the World Federation of Hemophilia (WFH) will organize the 9th Global Forum on Research and Treatment Products for Bleeding Disorders on October 22-23,...
Global community meets in the U.S. for the first time in over 25 years. Since the XIX International Congress of the World Federation of Hemophilia...
The 14th WFH International Musculoskeletal Congress held on May 7-10, 2015 in Belfast Northern Ireland was once again a huge success. The last four MSK...
To mark 2015 World Hemophilia day, World Federation of Hemophilia (WFH) staff banded together to help in achieving its vision of treatment for all. Twelve...
The World Federation of Hemophilia (WFH) organizes a Training the Trainers (TOT) workshop on laboratory diagnosis every two to three years. Since 2001, the aim...
Every year on April 17, World Hemophilia Day is observed around the world to increase awareness of hemophilia and other inherited bleeding disorders. This is...